한글목차

세계의 마이크로니들 시장 규모는 예측 기간 중 CAGR로 10.31%의 건전한 성장이 예측됩니다.

지역 인사이트

북미 시장은 2022년에 최대 시장 점유율을 차지했습니다. 이것은 탈모증 등 다양한 피부과 질환의 발생 증가와 최첨단 의료기관 및 우수한 전문가의 존재에 의한 것입니다.

유럽 시장은 2위의 시장 점유율을 차지하고 있습니다.

아시아태평양 시장은 2023-2030년에 발전할 전망입니다. 이것은 안티에이징 치료에 대한 관심의 확대, 생활 양식의 향상, 외과수술의 연구개발에 의한 것입니다.

세계의 마이크로니들 시장에 대해 조사분석했으며, 시장 역학, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장의 서론

제3장 조사 방법

제4장 시장 역학

• 개요
• 촉진요인
• 억제요인
• 기회

제5장 시장 요인 분석

• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
  • 수요에 대한 영향
  • 가격에 대한 영향
  • 주요 기업에 대한 영향

제6장 세계의 마이크로니들 시장 : 시술별

• 개요
• RF 마이크로니들
• 기존형 마이크로니들
• PRP 마이크로니들

제7장 세계의 마이크로니들 시장 : 제품별

• 개요
• 다마 스탬프
• 더마펜
• 더마롤러
• RF 마이크로니들 디바이스
• 기타

제8장 세계의 마이크로니들 시장 : 바늘 재료별

• 개요
• 실리콘
• 금속
• 유리
• 기타

제9장 세계의 마이크로니들 시장 : 용도별

• 개요
• 피부 회춘
• 여드름흉터
• 외상 및 수술에 의한 흉터
• 기타

제10장 세계의 마이크로니들 시장 : 최종사용자별

• 개요
• 병원
• 피부과 클리닉
• 홈케어 환경
• 기타

제11장 세계의 마이크로니들 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 기타 아시아태평양
• 기타 지역
  • 중동
  • 아프리카
  • 라틴아메리카

제12장 경쟁 구도

• 개요
• 경쟁 분석
• 시장 점유율 분석
• 세계의 마이크로니들 시장에서의 주요 성장 전략
• 경쟁 벤치마킹
• 세계의 마이크로니들 시장에서 개발수에서의 주요 기업
• 주요 발전과 성장 전략
  • 신제품 발매/서비스 도입
  • 합병과 인수
  • 합병사업
• 주요 기업의 재무 매트릭스
  • 판매와 영업이익(2022년)
  • 주요 기업의 연구개발 지출(2022년)

제13장 기업 개요

• CROWN AESTHETICS
• LUMENIS BE LTD
• AESTHETICS BIOMEDICAL
• INMODE
• LUTRONIC
• CYNOSURE
• CUTERA
• ENDYMED
• CANDELA CORPORATION
• DERMAROLLER GMBH

제14장 부록

영문목차

Market Outline

The Microneedling Market size is projected to enlist a sound CAGR of 10.31% during the conjecture time frame. The expansion is popular for negligibly obtrusive strategies, the ascent in the use of microneedling, and the developing clinical travel industry are driving market development.

Interest in insignificantly and harmless skin revival and body shaping methodology utilizing novel radiofrequency frameworks is developing at a fast speed. These insignificantly and harmless advancements have turned into the quickest developing areas of tasteful medication. Microneedling is an insignificantly obtrusive, non-ablative procedure ordinarily utilized for body molding, skin fixing, and cellulite decrease.

The greatest advantage of clinical travel is the expense of reserve funds since offices in immature countries can charge less due to the country's financial circumstances. In lacking nations, there is a lower GDP (Gross domestic product) per capita, which means lower wages. Moreover, costs for operations and medicines are far lower than in well-off nations.

Market Segmentation

The Market segments of Microneedling, based on procedure, include RF microneedling, traditional microneedling, and PRP microneedling. The product segment includes derma-stamp, dermapen, dermarollers, RF microneedling devices, and others.

Based on needle material the market is divided into silicon, metal, glass, and others. The Market segmentation of Microneedling is based on an application that includes, skin rejuvenation, acne scars, traumatic & surgical scars, and others. The end-user segment includes hospitals, dermatology clinics, home care settings, and others.

Regional Insights

The North American microneedling market represented the biggest market share in 2022. This is because of the rising occurrence of alopecia and different dermatological sicknesses and the presence of cutting-edge medical care offices and gifted experts in the region, and the rising vital association and expanding speculation by central parts in the region.

Europe microneedling market represents the second-biggest market share because of the developing help by government bodies for the utilization of negligibly obtrusive techniques, the rising number of item endorsements and the accessibility of items across the region, and the developing prevalence of insignificantly obtrusive innovation in the region.

The Asia-Pacific microneedling market is supposed to develop at a huge offer from 2023 to 2030. This is because of the expansion in the interest in antiaging treatment, the ascent in the way of life, and the development Research and development exercises in surgeries in the Asia-Pacific region.

Moreover, the developing buyer extra cash levels in arising nations and developing mechanical advancement are probably going to have extensive market development for microneedling.

The rest of the World is portioned into the Center East, Africa, and Latin America. The market for microneedling in the previously mentioned regions is probably going to observe development because of the rising commonness of negligibly obtrusive methodology and the rising stylish awareness among purchasers in these regions.

Major Players

Key Companies in the market of Microneedling include Crown Aesthetics (US), Lumenis Be Ltd (Israel), Aesthetics Biomedical (US), INMODE (US), LUTRONIC (US), Cynosure (US), Cutera (US), Endymed (US), Candela Corporation (US), and Dermaroller GmbH (Germany).

TABLE OF CONTENTS

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTIONS
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING MODALITY
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. IMPACT ON DEMAND
  • 5.3.2. IMPACT ON PRICING
  • 5.3.3. IMPACT ON KEY PLAYERS

6. GLOBAL MICRONEEDLING MARKET, BY PROCEDURE

• 6.1. OVERVIEW
• 6.2. RF MICRONEEDLING
• 6.3. TRADITIONAL MICRONEEDLING
• 6.4. PRP MICRONEEDLING

7. GLOBAL MICRONEEDLING MARKET, BY PRODUCT

• 7.1. OVERVIEW
• 7.2. DERMA-STAMP
• 7.3. DERMAPEN
• 7.4. DERMAROLLERS
• 7.5. RF MICRONEEDLING DEVICES
• 7.6. OTHERS

8. GLOBAL MICRONEEDLING MARKET, BY NEEDLE MATERIAL

• 8.1. OVERVIEW
• 8.2. SILICON
• 8.3. METAL
• 8.4. GLASS
• 8.5. OTHERS

9. GLOBAL MICRONEEDLING MARKET, BY APPLICATION

• 9.1. OVERVIEW
• 9.2. SKIN REJUVENATION
• 9.3. ACNE SCARS
• 9.4. TRAUMATIC & SURGICAL SCARS
• 9.5. OTHERS

10. GLOBAL MICRONEEDLING MARKET, BY END USER

• 10.1. OVERVIEW
• 10.2. HOSPITALS
• 10.3. DERMATOLOGY CLINICS
• 10.4. HOMECARE SETTINGS
• 10.5. OTHERS

11. GLOBAL MICRONEEDLING MARKET, BY REGION

• 11.1. OVERVIEW
• 11.1. NORTH AMERICA
  • 11.1.1. US
  • 11.1.2. CANADA
• 11.2. EUROPE
  • 11.2.1. GERMANY
  • 11.2.2. FRANCE
  • 11.2.3. UK
  • 11.2.4. ITALY
  • 11.2.5. SPAIN
  • 11.2.6. REST OF EUROPE
• 11.3. ASIA-PACIFIC
  • 11.3.1. CHINA
  • 11.3.2. INDIA
  • 11.3.3. JAPAN
  • 11.3.4. SOUTH KOREA
  • 11.3.5. AUSTRALIA
  • 11.3.6. REST OF ASIA-PACIFIC
• 11.4. REST OF THE WORLD
  • 11.4.1. MIDDLE EAST
  • 11.4.2. AFRICA
  • 11.4.3. LATIN AMERICA

12. COMPETITIVE LANDSCAPE

• 12.1. OVERVIEW
• 12.2. COMPETITIVE ANALYSIS
• 12.3. MARKET SHARE ANALYSIS
• 12.4. MAJOR GROWTH STRATEGY IN THE GLOBAL MICRONEEDLING MARKET,
• 12.5. COMPETITIVE BENCHMARKING
• 12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICRONEEDLING MARKET,
• 12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
  • 12.7.2. MERGER & ACQUISITIONS
  • 12.7.3. JOINT VENTURES
• 12.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 12.8.1. SALES & OPERATING INCOME, 2022
  • 12.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022

13. COMPANY PROFILES

• 13.1. CROWN AESTHETICS
  • 13.1.1. COMPANY OVERVIEW
  • 13.1.2. FINANCIAL OVERVIEW
  • 13.1.3. PRODUCTS OFFERED
  • 13.1.4. KEY DEVELOPMENTS
  • 13.1.5. SWOT ANALYSIS
  • 13.1.6. KEY STRATEGIES
• 13.2. LUMENIS BE LTD
  • 13.2.1. COMPANY OVERVIEW
  • 13.2.2. FINANCIAL OVERVIEW
  • 13.2.3. PRODUCTS OFFERED
  • 13.2.4. KEY DEVELOPMENTS
  • 13.2.5. SWOT ANALYSIS
  • 13.2.6. KEY STRATEGIES
• 13.3. AESTHETICS BIOMEDICAL
  • 13.3.1. COMPANY OVERVIEW
  • 13.3.2. FINANCIAL OVERVIEW
  • 13.3.3. PRODUCTS OFFERED
  • 13.3.4. KEY DEVELOPMENTS
  • 13.3.5. SWOT ANALYSIS
  • 13.3.6. KEY STRATEGIES
• 13.4. INMODE
  • 13.4.1. COMPANY OVERVIEW
  • 13.4.2. FINANCIAL OVERVIEW
  • 13.4.3. PRODUCTS OFFERED
  • 13.4.4. KEY DEVELOPMENTS
  • 13.4.5. SWOT ANALYSIS
  • 13.4.6. KEY STRATEGIES
• 13.5. LUTRONIC
  • 13.5.1. COMPANY OVERVIEW
  • 13.5.2. FINANCIAL OVERVIEW
  • 13.5.3. PRODUCTS OFFERED
  • 13.5.4. KEY DEVELOPMENTS
  • 13.5.5. SWOT ANALYSIS
  • 13.5.6. KEY STRATEGIES
• 13.6. CYNOSURE
  • 13.6.1. COMPANY OVERVIEW
  • 13.6.2. FINANCIAL OVERVIEW
  • 13.6.3. PRODUCTS OFFERED
  • 13.6.4. KEY DEVELOPMENTS
  • 13.6.5. SWOT ANALYSIS
  • 13.6.6. KEY STRATEGIES
• 13.7. CUTERA
  • 13.7.1. COMPANY OVERVIEW
  • 13.7.2. FINANCIAL OVERVIEW
  • 13.7.3. PRODUCTS OFFERED
  • 13.7.4. KEY DEVELOPMENTS
  • 13.7.5. SWOT ANALYSIS
  • 13.7.6. KEY STRATEGIES
• 13.8. ENDYMED
  • 13.8.1. COMPANY OVERVIEW
  • 13.8.2. FINANCIAL OVERVIEW
  • 13.8.3. PRODUCTS OFFERED
  • 13.8.4. KEY DEVELOPMENTS
  • 13.8.5. SWOT ANALYSIS
  • 13.8.6. KEY STRATEGIES
• 13.9. CANDELA CORPORATION
  • 13.9.1. COMPANY OVERVIEW
  • 13.9.2. FINANCIAL OVERVIEW
  • 13.9.3. PRODUCTS OFFERED
  • 13.9.4. KEY DEVELOPMENTS
  • 13.9.5. SWOT ANALYSIS
  • 13.9.6. KEY STRATEGIES
• 13.10. DERMAROLLER GMBH
  • 13.10.1. COMPANY OVERVIEW
  • 13.10.2. FINANCIAL OVERVIEW
  • 13.10.3. PRODUCTS OFFERED
  • 13.10.4. KEY DEVELOPMENTS
  • 13.10.5. SWOT ANALYSIS
  • 13.10.6. KEY STRATEGIES

14. APPENDIX

• 14.1. REFERENCES
• 14.2. RELATED REPORTS